Epigenetic regulation – modifications to the structure of chromatin that influence which genes are expressed in a cell – is a key player in embryonic development and cancer formation. Researchers at the European Molecular Biology Laboratory [EMBL] in Heidelberg now gained new insight into one crucial epigenetic mechanism and reveal that it acts much faster than assumed.
In this week's issue of Nature they report that estrogen causes rapid epigenetic changes in breast cancer cells. The new findings impact upon our understanding of how cells interpret their DNA and suggest that epigenetic regulation can affect gene expression immediately and long-term.
Epigenetic changes to the structure of chromatin – tightly packaged DNA - grant or deny access to the molecular machinery that transcribes DNA and thereby regulate gene expression. One of these mechanisms is DNA methylation, where a small chemical residue called a methyl group is added to strategic bases on the DNA. The methyl group prevents the transcription machinery from docking and thereby shuts down gene expression. For a long time scientists have considered methylation a mechanism of long-term regulation of a gene's activity, because the methylation marks are stable and maintained through cellular replication.
EMBL researchers of the group of Frank Gannon, current director of the Science Foundation Ireland, now found out that methylation marks occur rapidly in breast cancer cells in response to hormones such as estrogen or drug compounds. Estrogen withdrawal or treatment with the established anticancer drug doxorubicin cause the methyl groups to be removed from regulatory regions of specific genes within tens of minutes in human breast cancer cells. The treatment sets off a whole cycle of events: initial demethylation renders silent genes active and subsequent remethylation shuts them down again. This cycle repeats itself every 1.5 hours.
"We observed that unlike assumed for a long time methylation can act on a very short timescale. The results challenge our understanding of epigenetics as a means to regulate gene expression permanently," says Sara Kangaspeska, who carried out the research together with Brenda Stride.
The new insights into the cyclical nature of methylation might shed light on the molecular bases of cancer and development, both processes involving epigenetic mechanisms.
"In particular breast cancer is affected by estrogen signalling and changes in epigenetic control," says George Reid, co-senior author of the study. "Our next step will be to find small molecules that target the cyclical methylation processes to elucidate their precise role."
Published in Nature on 6 March 2008.
Anna-Lynn Wegener | EMBL
Computer simulations visualize how DNA is recognized to convert cells into stem cells
17.02.2020 | Max-Planck-Institut für molekulare Biomedizin
Researchers at the University of Freiburg use new method to investigate neural oscillations
14.02.2020 | Albert-Ludwigs-Universität Freiburg im Breisgau
Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices
The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...
Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.
Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.
After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.
"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.
Superconductivity approaching room temperature may be possible in hydrogen-rich compounds at much lower pressures than previously expected
Reaching room-temperature superconductivity is one of the biggest dreams in physics. Its discovery would bring a technological revolution by providing...
At the end of December 2019, the first cases of pneumonia caused by a novel coronavirus were reported from the Chinese city of Wuhan. Since then, infections...
12.02.2020 | Event News
16.01.2020 | Event News
15.01.2020 | Event News
17.02.2020 | Physics and Astronomy
17.02.2020 | Materials Sciences
17.02.2020 | Life Sciences